IPO Search Results for JATT II Acquisition

Company	Ticker	Business Description	Underwriters	Offer Date
JATT II Acquisition	JATT	Blank check company targeting biotechs and life sciences businesses (pending: Talawar Therapeutics).	Guggenheim Sec.	04/16/26
JATT III Acquisition	JTTT	Blank check company formed by biotech entrepreneurs targeting life sciences businesses.	Guggenheim Sec.	08/25/26

News Results for JATT II Acquisition
SPAC JATT III Acquisition prices $60 million IPO, targeting biotech and life sciences 08/26/26
SPAC JATT III Acquisition files for a $60 million IPO, following prior SPAC's deal with Talawar Therapeutics 08/10/26
US IPO Weekly Recap: IPO calendar heats up as AI chipmaker Cerebras rejoins the public pipeline 04/17/26
SPAC JATT II Acquisition prices $60 million IPO, targeting biotech and life sciences 04/17/26
US IPO Weekly Recap: PayPay prices US IPO below the range but climbs 32% 03/13/26
SPAC JATT II Acquisition files for a $60 million IPO, targeting biotech and life sciences 03/13/26